Estamos no ar no !
Saiba mais
Estrella Immunopharma Warrant
ESLAW
ESLAW
Sobre: Estrella Immunopharma Inc is a clinical-stage biopharmaceutical company. The company is engaged in developing CD19 and CD22-targeted ARTEMIS T-cell therapies with the capacity to address treatment challenges for patients with blood cancers and solid tumors.
Notícias
Positivo
Neutro
Negativo
Sentimento
3 meses
Positivo
0%
Neutro
0%
Negativo
0%
Não recebemos notícias recentes sobre ESLAW
Gráficos de preços implementados com Lightweight Charts™